UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...

A Crew Dragon spacecraft docked with the International Space Station on Valentine’s Day, and astronauts popped open the hatches at 5:14 pm ET (22:14 UTC) on Saturday evening. The arrival of four new ...

Abstract: Capturing stationary aerial objects on unmanned surface vehicles (USVs) is challenging due to quasiperiodic and fast floating-base motions caused by wave-induced disturbances. It is hard to ...

Abstract: This article presents an improved method of measuring technology similarity by introducing a subject-action-object (SAO) analysis that uses the feature weights of semantic structure and ...

(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...

Biotech company Complement Therapeutics, which has facilities at Stevenage Bioscience Catalyst, has received a major Transatlantic boost from the FDA in America. CTx, which is developing nextgen ...

'Like Any Sovereign Country...': Russia Threatens Retaliation If Planes Downed In Its Airspace Chinese woman survives 54 hours in abandoned well battling water snakes Did Kayadu Lohar's close friend ...

In myasthenia gravis, complement plays a big role in what happens to the muscle end of the neuromuscular junction, explains Miriam Freimer, MD, an author on 5 abstracts presented at the recent 15th ...

Great apes track events with their eyes in the same way that humans do, according to a new study. Great apes track events with their eyes in the same way that humans do, according to a study published ...

A chimpanzee watching a video of an agent (left) brushing the hair of a patient (right). Red circles indicate her gaze fixations, and red lines indicate attentional switching between agent and patient ...

DelveInsight’s 'Complement Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline complement inhibitors in various stages of clinical development, major ...

K. pneumoniae is frequently the source of hospital-acquired infections and, due to the widespread use of antibiotics in these settings, has also acquired numerous resistance genes. In fact, over ...